IMAB
Price
$2.45
Change
+$0.16 (+6.99%)
Updated
Jun 6 closing price
Capitalization
186.19M
86 days until earnings call
RPRX
Price
$33.78
Change
+$0.03 (+0.09%)
Updated
Jun 6 closing price
Capitalization
14.23B
59 days until earnings call
Interact to see
Advertisement

IMAB vs RPRX

Header iconIMAB vs RPRX Comparison
Open Charts IMAB vs RPRXBanner chart's image
I-MAB
Price$2.45
Change+$0.16 (+6.99%)
Volume$1.68M
Capitalization186.19M
Royalty Pharma
Price$33.78
Change+$0.03 (+0.09%)
Volume$2.74M
Capitalization14.23B
IMAB vs RPRX Comparison Chart
Loading...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMAB vs. RPRX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMAB is a Buy and RPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (IMAB: $1.17 vs. RPRX: $32.63)
Brand notoriety: IMAB and RPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMAB: 546% vs. RPRX: 59%
Market capitalization -- IMAB: $186.19M vs. RPRX: $14.23B
IMAB [@Biotechnology] is valued at $186.19M. RPRX’s [@Biotechnology] market capitalization is $14.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMAB’s FA Score shows that 0 FA rating(s) are green whileRPRX’s FA Score has 2 green FA rating(s).

  • IMAB’s FA Score: 0 green, 5 red.
  • RPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, RPRX is a better buy in the long-term than IMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMAB’s TA Score shows that 5 TA indicator(s) are bullish while RPRX’s TA Score has 6 bullish TA indicator(s).

  • IMAB’s TA Score: 5 bullish, 4 bearish.
  • RPRX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RPRX is a better buy in the short-term than IMAB.

Price Growth

IMAB (@Biotechnology) experienced а +24.05% price change this week, while RPRX (@Biotechnology) price change was -0.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

IMAB is expected to report earnings on Sep 02, 2025.

RPRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($14.2B) has a higher market cap than IMAB($186M). IMAB YTD gains are higher at: 37.647 vs. RPRX (29.622). IMAB has less debt than RPRX: IMAB (3.78M) vs RPRX (7.61B).
IMABRPRXIMAB / RPRX
Capitalization186M14.2B1%
EBITDA-212.17MN/A-
Gain YTD37.64729.622127%
P/E RatioN/A13.78-
Revenue3.27MN/A-
Total Cash184MN/A-
Total Debt3.78M7.61B0%
FUNDAMENTALS RATINGS
RPRX: Fundamental Ratings
RPRX
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
76

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMABRPRX
RSI
ODDS (%)
Bearish Trend 12 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
81%
Bullish Trend 12 days ago
54%
Momentum
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 12 days ago
48%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
76%
Bearish Trend 12 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
45%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 21 days ago
51%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 18 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
82%
Aroon
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

IMAB and

Correlation & Price change

A.I.dvisor tells us that IMAB and RPRX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMAB and RPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
+12.50%
RPRX - IMAB
31%
Poorly correlated
-0.18%
IRD - IMAB
31%
Poorly correlated
-1.47%
TPST - IMAB
28%
Poorly correlated
+1.94%
LGND - IMAB
27%
Poorly correlated
-1.43%
UBX - IMAB
26%
Poorly correlated
-7.71%
More

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with INCY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then INCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
-0.18%
INCY - RPRX
36%
Loosely correlated
-0.64%
GLPG - RPRX
33%
Loosely correlated
+0.55%
SEER - RPRX
33%
Loosely correlated
+1.53%
XNCR - RPRX
31%
Poorly correlated
-2.58%
IMAB - RPRX
31%
Poorly correlated
+12.50%
More